The University of Nevada, Reno School of Medicine

The IL-13 Story in Atopic Dermatitis: Characterizing Pathways and Therapeutic Performance

Examine the pathophysiological pathways of atopic dermatitis (AD) and the impact of interleukin (IL)-13 on disease severity and chronicity 

Utilize the latest clinical data to differentiate available biologic IL-13 therapies and guide therapy selection 

Evaluate the safety and efficacy of emerging IL-13 therapies to support timely integration into clinical practice 